Inventor
WAYNE C. DREVETS
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07BGeneral methods of organic chemistry7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
PatentTitleYear
12,419,859Compositions and methods for the treatment of depression202512,201,610Compositions comprising aticaprant202512,201,634Methods of treating depression using orexin-2 receptor antagonists202512,171,743Forms of aticaprant202412,161,622Compositions and methods for the treatment of depression202412,150,929Compositions and methods for the treatment of depression202411,998,524Forms of aticaprant202411,998,525Compositions and methods for the treatment of depression202411,311,500Methods for the treatment of depression202211,266,627Compositions and methods for the treatment of depression202211,241,432Methods of treating depression using orexin-2 receptor antagonists202211,173,134Methods for the treatment of depression2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to JANSSEN PHARMACEUTICALS INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICALS INC | 8 | 2022–2025 |
| JANSSEN PHARMACEUTICA NV | 4 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2021–2025 |